AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Rebui, JC Waser, B Schaer, JC Laissue, JA
Citation: Jc. Rebui et al., Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands (vol 28, pg 1433, 2001), EUR J NUCL, 28(9), 2001, pp. 1433-1433

Authors: Reubi, JC Waser, B Schaer, JC Laissue, JA
Citation: Jc. Reubi et al., Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands, EUR J NUCL, 28(7), 2001, pp. 836-846

Authors: Rivier, JE Hoeger, C Erchegyi, J Gulyas, J DeBoard, R Craig, AG Koerber, SC Wenger, S Waser, B Schaer, JC Reubi, JC
Citation: Je. Rivier et al., Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1), J MED CHEM, 44(13), 2001, pp. 2238-2246

Authors: Hannon, JP Langenegger, D Waser, B Hoyer, D Reubi, JC
Citation: Jp. Hannon et al., Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors, EUR J PHARM, 426(3), 2001, pp. 165-173

Authors: Reubi, JC Gugger, M Waser, B Schaer, JC
Citation: Jc. Reubi et al., Y-1-mediated effect of neuropeptide Y in cancer: Breast carcinomas as targets, CANCER RES, 61(11), 2001, pp. 4636-4641

Authors: Reubi, JC Schar, JC Waser, B Wenger, S Heppeler, A Schmitt, JS Macke, HR
Citation: Jc. Reubi et al., Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use, EUR J NUCL, 27(3), 2000, pp. 273-282

Authors: Reubi, JC Schaer, JC Wenger, S Hoeger, C Erchegyi, J Waser, B Rivier, J
Citation: Jc. Reubi et al., SST3-selective potent peptidic somatostatin receptor antagonists, P NAS US, 97(25), 2000, pp. 13973-13978

Authors: Reubi, JC Waser, B Liu, QS Laissue, JA Schonbrunn, A
Citation: Jc. Reubi et al., Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: Membranous versus intracellular location, J CLIN END, 85(10), 2000, pp. 3882-3891

Authors: Reubi, JC Laderach, U Waser, B Gebbers, JO Robberecht, P Laissue, JA
Citation: Jc. Reubi et al., Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin, CANCER RES, 60(11), 2000, pp. 3105-3112

Authors: Reubi, JC Laissue, JA Waser, B Steffen, DL Hipkin, RW Schonbrunn, A
Citation: Jc. Reubi et al., Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: Facts and artifacts, J CLIN END, 84(8), 1999, pp. 2942-2950

Authors: Reubi, JC Waser, B Schaer, JC Laissue, JA
Citation: Jc. Reubi et al., Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomas, INT J CANC, 82(2), 1999, pp. 213-218

Authors: Reubi, JC Waser, B Schmassmann, A Laissue, JA
Citation: Jc. Reubi et al., Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: Where are they really located?, INT J CANC, 81(3), 1999, pp. 376-386

Authors: Reubi, JC Zimmermann, A Jonas, S Waser, B Neuhaus, P Laderach, U Wiedenmann, B
Citation: Jc. Reubi et al., Regulatory peptide receptors in human hepatocellular carcinomas, GUT, 45(5), 1999, pp. 766-774
Risultati: 1-13 |